Autosomal dominant polycystic kidney disease: modification of disease progression

被引:65
作者
Peters, DJM [1 ]
Breuning, MH [1 ]
机构
[1] Leiden Univ, Med Ctr, Dept Human & Clin Genet, NL-2333 AL Leiden, Netherlands
关键词
D O I
10.1016/S0140-6736(01)06531-X
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Autosomal dominant polycystic kidney disease is a common inherited disorder, which is characterised by the formation of fluid-filled cysts in both kidneys that leads to progressive renal failure. Mutations in two genes, PKD1 and PKD2, are associated with the disorder. We describe the various factors that cause variation in disease progression between patients. These include whether the patient has a germline mutation in the PKD1 or in the PKD2 gene, and the nature of the mutation. Detection of mutations in PKD1 is complicated, but the total number identified is rising and will enable genotype-to-phenotype studies. Another factor affecting disease progression is the occurrence of somatic mutations in PKD genes. Furthermore, modifying genes might directly affect the function of polycystins by affecting the rate of somatic mutations or the rate of protein interactions, or they might affect cystogenesis itself or clinical factors associated with disease progression. Finally, environmental factors that speed up or slow down progress towards chronic renal failure have been identified in rodents.
引用
收藏
页码:1439 / 1444
页数:6
相关论文
共 89 条
[61]   Lack of association of ACE/angiotensinogen genotype with renal function in autosomal dominant polycystic kidney disease [J].
Saggar-Malik, AK ;
Afzal, AR ;
Swissman, JS ;
Bland, M ;
Sagnella, GA ;
Eastwood, JB ;
MacGregor, GA ;
Jeffrey, S .
GENETIC TESTING, 2000, 4 (03) :299-303
[62]   Comparative analysis of the polycystic kidney disease 1 (PKD1) gene reveals an integral membrane glycoprotein with multiple evolutionary conserved domains [J].
Sandford, R ;
Sgotto, B ;
Aparicio, S ;
Brenner, S ;
Vaudin, M ;
Wilson, RK ;
Chissoe, S ;
Pepin, K ;
Bateman, A ;
Chothia, C ;
Hughes, J ;
Harris, P .
HUMAN MOLECULAR GENETICS, 1997, 6 (09) :1483-1489
[63]   Polycystin-1, the product of the polycystic kidney disease 1 gene, co-localizes with desmosomes in MDCK cells [J].
Scheffers, MS ;
van der Bent, P ;
Prins, F ;
Spruit, L ;
Breuning, MH ;
Litvinov, SV ;
de Heer, E ;
Peters, DJM .
HUMAN MOLECULAR GENETICS, 2000, 9 (18) :2743-2750
[64]   Effects of potassium citrate/citric acid intake in a mouse model of polycystic kidney disease [J].
Tanner, GA ;
Vijayalakshmi, K ;
Tanner, JA .
NEPHRON, 2000, 84 (03) :270-273
[65]   Citrate therapy for polycystic kidney disease in rats [J].
Tanner, GA ;
Tanner, JA .
KIDNEY INTERNATIONAL, 2000, 58 (05) :1859-1869
[66]   Identification of mutations in the repeated part of the autosomal dominant polycystic kidney disease type 1 gene, PKD1, by long-range PCR [J].
Thomas, R ;
McConnell, R ;
Whittacker, J ;
Kirkpatrick, P ;
Bradley, J ;
Sandford, R .
AMERICAN JOURNAL OF HUMAN GENETICS, 1999, 65 (01) :39-49
[67]   A loss-of-function model for cystogenesis in human autosomal dominant polycystic kidney disease type 2 [J].
Torra, R ;
Badenas, C ;
San Millán, JL ;
Pérez-Oller, L ;
Estivill, X ;
Darnell, A .
AMERICAN JOURNAL OF HUMAN GENETICS, 1999, 65 (02) :345-352
[68]  
Torres VE, 2001, EXP NEPHROL, V9, P171
[69]   Specific association of the gene product of PKD2 with the TRPC1 channel [J].
Tsiokas, L ;
Arnould, T ;
Zhu, CW ;
Kim, E ;
Walz, G ;
Sukhatme, VP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (07) :3934-3939
[70]   Homo- and heterodimeric interactions between the gene products of PKD1 and PKD2 [J].
Tsiokas, L ;
Kim, E ;
Arnould, T ;
Sukhatme, VP ;
Walz, G .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (13) :6965-6970